News
-
-
-
COMMUNIQUÉ DE PRESSE
Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit
Adolore BioTherapeutics to present innovative opioid-free chronic pain treatments at the 18th Annual Pain Therapeutics Summit in Boston, Ma, based on cutting-edge CA8* analgesic peptides & rdHSV vectors technology -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Adolore BioTherapeutics Announces Publication of Compelling Preclinical Efficacy and Safety Data Supporting Adolore's Non-opioid Analgesic Gene Therapy, ADLR-1001, For Treatment of Moderate to Severe Chronic Knee Pain Due to Osteoarthritis (OA)
Adolore BioTherapeutics validates a non-opioid analgesic gene therapy for chronic pain via local delivery to sensory neurons. Preclinical study supports opioid-free treatment for chronic knee pain due to OA -
